TP53 and Lynch syndrome: An increasing number of constitutive carriers of cancer genetic predispositions, such as BRCA1/2, TP53, Lynch syndrome mutations, and Noonan syndrome mutations, have been found due to the advances in clinical genomic tests with high-throughput sequencing techniques.